Hims & Hers Health has launched injectable and oral testosterone replacement therapies (TRT), its largest expansion of the men’s health program to date. Eligible men can access the treatments through the Hims platform in partnership with licensed providers.
The company estimates that 20 million men in the U.S. are affected by low testosterone, which can lead to lower energy, reduced muscle mass and lower sex drive.
The expansion aims to raise awareness of treatment options and make care more accessible.